Overview

An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension

Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
Effect of increasing doses of olmesartan medoxomil and olmesartan medoxomil/hydrochlorothiazide on blood pressure in patients with hypertension
Phase:
Phase 4
Details
Lead Sponsor:
Daiichi Sankyo Inc.
Daiichi Sankyo, Inc.
Treatments:
Hydrochlorothiazide
Olmesartan
Olmesartan Medoxomil